Barnes, Emily M. E.
Xu, Yitao
Benito, Adrian
Herendi, Lili
Siskos, Alexandros P.
Aboagye, Eric O.
Nijhuis, Anke
Keun, Hector C. https://orcid.org/0000-0001-7358-8851
Funding for this research was provided by:
Imperial ECMC & NIHR Imperial BRC
EC | Horizon 2020 Framework Programme (737978)
Article History
Received: 10 June 2019
Revised: 7 February 2020
Accepted: 18 February 2020
First Online: 10 March 2020
Ethics approval and consent to participate
: No human or animal ethics approval was required for this study. The LS174T cells were received as a generous gift from Prof. Jacques Pouysségur at the University of Nice, Nice, France. The HCT116 cells were received as a generous gift from Dr Volker Arlt at King’s College London, London, United Kingdom.
: Data generated for the current study are available from the corresponding author on reasonable request.
: The authors declare no competing interests.
: The research was funded by Cancer Research UK Imperial Centre at Imperial College London (C17375/ A19482) and by MetaCell-TM H2020 Fast Track to Innovation (737978). A.P.S. was funded by Imperial Experimental Cancer Medicine Centre & National Institute for Health Research (NIHR) Imperial Biomedical Research Centre (BRC).